Cargando…
COVID Vaccine Rollout for Older Adults in France
Only about three million people in France have so far received at least one dose of a Covid-19 vaccine. Those aged over 75 are offered either Pfizer or Moderna vaccines in a vaccination center. Older people with pre-existing conditions can now get AstraZeneca's Covid-19 vaccine. We will provide...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754860/ http://dx.doi.org/10.1093/geroni/igab046.715 |
_version_ | 1784632335902179328 |
---|---|
author | De Stampa, Matthieu |
author_facet | De Stampa, Matthieu |
author_sort | De Stampa, Matthieu |
collection | PubMed |
description | Only about three million people in France have so far received at least one dose of a Covid-19 vaccine. Those aged over 75 are offered either Pfizer or Moderna vaccines in a vaccination center. Older people with pre-existing conditions can now get AstraZeneca's Covid-19 vaccine. We will provide detailed information later. The symposium has experts from 8 countries. We will use an interview and dialog format, instead of presentations (please refer to the program overview). |
format | Online Article Text |
id | pubmed-8754860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-87548602022-01-13 COVID Vaccine Rollout for Older Adults in France De Stampa, Matthieu Innov Aging Abstracts Only about three million people in France have so far received at least one dose of a Covid-19 vaccine. Those aged over 75 are offered either Pfizer or Moderna vaccines in a vaccination center. Older people with pre-existing conditions can now get AstraZeneca's Covid-19 vaccine. We will provide detailed information later. The symposium has experts from 8 countries. We will use an interview and dialog format, instead of presentations (please refer to the program overview). Oxford University Press 2021-12-17 /pmc/articles/PMC8754860/ http://dx.doi.org/10.1093/geroni/igab046.715 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstracts De Stampa, Matthieu COVID Vaccine Rollout for Older Adults in France |
title | COVID Vaccine Rollout for Older Adults in France |
title_full | COVID Vaccine Rollout for Older Adults in France |
title_fullStr | COVID Vaccine Rollout for Older Adults in France |
title_full_unstemmed | COVID Vaccine Rollout for Older Adults in France |
title_short | COVID Vaccine Rollout for Older Adults in France |
title_sort | covid vaccine rollout for older adults in france |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754860/ http://dx.doi.org/10.1093/geroni/igab046.715 |
work_keys_str_mv | AT destampamatthieu covidvaccinerolloutforolderadultsinfrance |